Company Profile

Abbratech Inc
Profile last edited on: 10/25/2023      CAGE: 8VPC6      UEI: G7S7M6L41EX5

Business Identifier: Recombinant antibodies: discovery and development services
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

25 Business Park Drive Suite C
Branford, CT 06405
   (203) 606-5394
Location: Single
Congr. District: 03
County: New Haven

Public Profile

Launched by a team of experienced life science industry researchers. Abbratech Inc is structured around addressing various problems in the antibody development paradigm; that facts that the current systems are too slow and do not always result in consistent, renewable, and precise antibodies. The technology and approach devised by AbbratechÂ’s - designated EPIVOLVEsm technology - provides a comprehensive custom recombinant antibody discovery and development services platform.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Michael P Weiner -- CEO & Founder

  Xiaofeng Li

  Linda Stevens -- Executive Director

Company News

There are no news available.